{"id":1042,"date":"2024-02-25T14:53:09","date_gmt":"2024-02-25T13:53:09","guid":{"rendered":"https:\/\/www.utopiasis.it\/?page_id=1042"},"modified":"2024-03-08T08:13:52","modified_gmt":"2024-03-08T07:13:52","slug":"drug-discovery-and-clinic-srl","status":"publish","type":"page","link":"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/","title":{"rendered":"Drug Discovery and Clinic Srl"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”sezione blocco 1″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”gcid-ac150a38-2027-4fd4-8963-25e8b6f6f839″ custom_margin=”85px||||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{%22gcid-ac150a38-2027-4fd4-8963-25e8b6f6f839%22:%91%22background_color%22%93}”][et_pb_row column_structure=”1_2,1_2″ use_custom_gutter=”on” gutter_width=”1″ make_equal=”on” _builder_version=”4.24.2″ _module_preset=”default” width=”100%” max_width=”100%” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.24.2″ _module_preset=”default” background_image=”https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/foto1vs1.webp” background_enable_video_mp4=”off” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/DDC.png” title_text=”DDC” _builder_version=”4.24.2″ _module_preset=”default” background_color=”#FFFFFF” positioning=”absolute” position_origin_a=”bottom_left” width=”35%” custom_margin=”||||false|false” custom_padding=”20px|20px|20px|20px|false|false” locked=”off” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.24.2″ _module_preset=”default” custom_padding=”100px|60px|100px|60px|true|true” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” header_2_text_color=”gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14″ header_2_font_size=”30px” custom_margin=”||0px||false|false” locked=”off” global_colors_info=”{%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22header_2_text_color%22%93}”]<\/p>\n

DRUG DISCOVERY AND CLINIC<\/h2>\n

[\/et_pb_text][et_pb_divider color=”gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14″ _builder_version=”4.24.2″ _module_preset=”default” custom_margin=”||0px||false|false” custom_padding=”||||false|false” locked=”off” global_colors_info=”{%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22color%22%93}”][\/et_pb_divider][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” header_4_text_color=”gcid-b7a20a05-ac47-46ee-846a-44540a53bb38″ header_4_line_height=”1.4em” global_colors_info=”{%22gcid-b7a20a05-ac47-46ee-846a-44540a53bb38%22:%91%22header_4_text_color%22%93}”]<\/p>\n

DRUG DISCOVERY AND CLINIC: HDHODH INHIBITORS TO FIGHT LEUKEMIA<\/h4>\n

[\/et_pb_text][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” text_text_color=”#000000″ text_font_size=”17px” text_line_height=”1.8em” text_orientation=”justified” global_colors_info=”{}”]<\/p>\n

The company, a spin-off from the University of Turin, has developed a molecule with antitumor purposes belonging to the family of HDHODH inhibitors.<\/p>\n

To date, the main tests conducted by the company, both in vitro and in vivo, have been directed towards the tumor form of Acute Myeloid Leukemia (AML), and other in vitro tests have been carried out with promising results on some forms of solid tumors (including Triple Negative Breast Cancer).<\/p>\n

The company’s goal is therefore aimed at developing a technological platform aimed at developing treatments for leukemias and solid tumors.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_6,1_6,1_6″ use_custom_gutter=”on” gutter_width=”1″ make_equal=”on” _builder_version=”4.24.2″ _module_preset=”default” width=”100%” max_width=”100%” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.24.2″ _module_preset=”default” custom_padding=”100px|60px|100px|60px|true|true” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” text_text_color=”#000000″ text_font_size=”17px” text_line_height=”1.8em” text_orientation=”justified” global_colors_info=”{}”]The company is initiating a collaboration with the Catholic University of the Sacred Heart to test its molecule on pediatric Glioblastoma (currently incurable).<\/p>\n

The team, qualified and multidisciplinary, includes Prof. Giuseppe Saglio, Prof. Giovanni Martinelli, Prof. Donatella Boschi, and Prof. Marco Lucio Lolli.<\/p>\n

Utopia invested in October 2022.[\/et_pb_text][et_pb_blurb title=”www.ddcpharmaceutical.com” url=”https:\/\/ddcpharmaceutical.com” url_new_window=”on” use_icon=”on” font_icon=”I||divi||400″ icon_color=”gcid-b7a20a05-ac47-46ee-846a-44540a53bb38″ icon_placement=”left” _builder_version=”4.24.2″ _module_preset=”default” header_font=”||||||||” header_font_size=”17px” custom_margin=”||||false|false” custom_padding=”30px||||false|false” global_colors_info=”{%22gcid-b7a20a05-ac47-46ee-846a-44540a53bb38%22:%91%22icon_color%22%93}”][\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14″ custom_padding=”30px|20px|0px|20px|false|true” global_colors_info=”{%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22background_color%22%93}”][et_pb_image src=”https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/parlano-di-noi-1.png” title_text=”parlano di noi (1)” url=”https:\/\/bebeez.it\/venture-capital\/quinto-deal-per-utopia-che-investe-15-mln-euro-sulla-ricerca-antitumorale-di-drug-discovery-clinic\/” url_new_window=”on” _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_image src=”https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/8.png” title_text=”8″ url=”https:\/\/startupitalia.eu\/startup\/investimenti\/round-da-15-milioni-di-euro-per-ddc-spin-off-delluniversita-di-torino\/” url_new_window=”on” _builder_version=”4.24.2″ _module_preset=”default” custom_margin=”30px||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14″ custom_padding=”30px|20px|0px|20px|false|true” global_colors_info=”{%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22background_color%22,%22background_color%22%93}”][et_pb_image src=”https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/parlano-di-noi.png” title_text=”parlano di noi” url=”https:\/\/financecommunity.it\/utopia-sis-investe-in-ddc-un-milione-e-mezzo-di-euro\/” url_new_window=”on” _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14″ custom_padding=”30px|20px|0px|20px|false|true” global_colors_info=”{%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22background_color%22,%22background_color%22%93}”][et_pb_image src=”https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/parlano-di-noi-3.png” title_text=”parlano di noi (3)” url=”https:\/\/dealflower.it\/health-utopia-sis-investe-15-milioni-in-ddc\/” url_new_window=”on” _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”gcid-b7a20a05-ac47-46ee-846a-44540a53bb38″ background_enable_mask_style=”on” background_mask_style=”triangles” background_mask_color=”gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14″ background_mask_transform=”invert” locked=”off” global_colors_info=”{%22gcid-b7a20a05-ac47-46ee-846a-44540a53bb38%22:%91%22background_color%22%93,%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22background_mask_color%22%93}”][et_pb_row column_structure=”1_4,1_2,1_4″ use_custom_gutter=”on” gutter_width=”2″ make_equal=”on” _builder_version=”4.24.2″ _module_preset=”default” width=”90%” max_width=”100%” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=jvuNa-17G4s” _builder_version=”4.24.2″ _module_preset=”default” custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_video][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

DRUG DISCOVERY AND CLINICDRUG DISCOVERY AND CLINIC: HDHODH INHIBITORS TO FIGHT LEUKEMIAThe company, a spin-off from the University of Turin, has developed a molecule with antitumor purposes belonging to the family of HDHODH inhibitors. To date, the main tests conducted by the company, both in vitro and in vivo, have been directed towards the tumor […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[et_pb_section fb_built=\"1\" admin_label=\"sezione blocco 1\" _builder_version=\"4.24.2\" _module_preset=\"default\" background_color=\"gcid-ac150a38-2027-4fd4-8963-25e8b6f6f839\" custom_margin=\"85px||||false|false\" custom_padding=\"0px||0px||false|false\" global_colors_info=\"{%22gcid-ac150a38-2027-4fd4-8963-25e8b6f6f839%22:%91%22background_color%22%93}\"][et_pb_row column_structure=\"1_2,1_2\" use_custom_gutter=\"on\" gutter_width=\"1\" make_equal=\"on\" _builder_version=\"4.24.2\" _module_preset=\"default\" width=\"100%\" max_width=\"100%\" custom_padding=\"0px||0px||false|false\" global_colors_info=\"{}\"][et_pb_column type=\"1_2\" _builder_version=\"4.24.2\" _module_preset=\"default\" background_image=\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/foto1vs1.webp\" background_enable_video_mp4=\"off\" global_colors_info=\"{}\"][et_pb_image src=\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/DDC.png\" title_text=\"DDC\" _builder_version=\"4.24.2\" _module_preset=\"default\" background_color=\"#FFFFFF\" positioning=\"absolute\" position_origin_a=\"bottom_left\" width=\"35%\" custom_margin=\"||||false|false\" custom_padding=\"20px|20px|20px|20px|false|false\" locked=\"off\" global_colors_info=\"{}\"][\/et_pb_image][\/et_pb_column][et_pb_column type=\"1_2\" _builder_version=\"4.24.2\" _module_preset=\"default\" custom_padding=\"100px|60px|100px|60px|true|true\" global_colors_info=\"{}\"][et_pb_text _builder_version=\"4.24.2\" _module_preset=\"default\" header_2_text_color=\"gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14\" header_2_font_size=\"30px\" custom_margin=\"||0px||false|false\" locked=\"off\" global_colors_info=\"{%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22header_2_text_color%22%93}\"]\n

DRUG DISCOVERY AND CLINIC<\/h2>\n[\/et_pb_text][et_pb_divider color=\"gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14\" _builder_version=\"4.24.2\" _module_preset=\"default\" custom_margin=\"||0px||false|false\" custom_padding=\"||||false|false\" locked=\"off\" global_colors_info=\"{%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22color%22%93}\"][\/et_pb_divider][et_pb_text _builder_version=\"4.24.2\" _module_preset=\"default\" header_4_text_color=\"gcid-b7a20a05-ac47-46ee-846a-44540a53bb38\" header_4_line_height=\"1.4em\" global_colors_info=\"{%22gcid-b7a20a05-ac47-46ee-846a-44540a53bb38%22:%91%22header_4_text_color%22%93}\"]\n

DRUG DISCOVERY AND CLINIC: HDHODH INIBITORI PER COMBATTERE LA LEUCEMIA<\/h4>\n[\/et_pb_text][et_pb_text _builder_version=\"4.24.2\" _module_preset=\"default\" text_text_color=\"#000000\" text_font_size=\"17px\" text_line_height=\"1.8em\" text_orientation=\"justified\" global_colors_info=\"{}\"]\n\nLa societ\u00e0, Spin-off dell\u2019Universit\u00e0 di Torino, ha sviluppato una molecola con fini antitumorali della famiglia degli HDHODH inibitori. Ad oggi i principali test effettuati dalla societ\u00e0 sia in vitro che in vivo sono stati indirizzati sulla forma tumorale della Leucemia Meloide Acuta (AML) e altri test in vitro sono stati svolti con buoni risultati su alcune forme di tumori solidi (tra cui il Tumore al Seno Triplo Negativo).\n\nL\u2019obiettivo della societ\u00e0 \u00e8 quindi volto allo sviluppo di una piattaforma tecnologica che avr\u00e0 come fine la messa a punto di cure per le leucemie e per i tumori solidi.\n\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\"1_2,1_6,1_6,1_6\" use_custom_gutter=\"on\" gutter_width=\"1\" make_equal=\"on\" _builder_version=\"4.24.2\" _module_preset=\"default\" width=\"100%\" max_width=\"100%\" custom_padding=\"0px||0px||false|false\" global_colors_info=\"{}\"][et_pb_column type=\"1_2\" _builder_version=\"4.24.2\" _module_preset=\"default\" custom_padding=\"100px|60px|100px|60px|true|true\" global_colors_info=\"{}\"][et_pb_text _builder_version=\"4.24.2\" _module_preset=\"default\" text_text_color=\"#000000\" text_font_size=\"17px\" text_line_height=\"1.8em\" text_orientation=\"justified\" hover_enabled=\"0\" global_colors_info=\"{}\" sticky_enabled=\"0\"]\n\nLa societ\u00e0 sta avviando una collaborazione con l\u2019universit\u00e0 cattolica del Sacro Cuore per testare la propria molecola sul Glioblastoma pediatrico (ad oggi incurabile).\n\nIl team, qualificato e multi disciplinare, \u00e8 composto dal Prof. Giuseppe Saglio, dal Prof. Giovanni Martinelli, dalla Prof.ssa Donatella Boschi e dal Prof. Marco Lucio Lolli.\n\nUtopia ha investito nel mese di ottobre 2022.\n\n[\/et_pb_text][et_pb_blurb title=\"www.ddcpharmaceutical.com\" url=\"https:\/\/ddcpharmaceutical.com\" url_new_window=\"on\" use_icon=\"on\" font_icon=\"I||divi||400\" icon_color=\"gcid-b7a20a05-ac47-46ee-846a-44540a53bb38\" icon_placement=\"left\" _builder_version=\"4.24.2\" _module_preset=\"default\" header_font=\"||||||||\" header_font_size=\"17px\" custom_margin=\"||||false|false\" custom_padding=\"30px||||false|false\" global_colors_info=\"{%22gcid-b7a20a05-ac47-46ee-846a-44540a53bb38%22:%91%22icon_color%22%93}\"][\/et_pb_blurb][\/et_pb_column][et_pb_column type=\"1_6\" _builder_version=\"4.24.2\" _module_preset=\"default\" background_color=\"gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14\" custom_padding=\"30px|20px|0px|20px|false|true\" global_colors_info=\"{%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22background_color%22%93}\"][et_pb_image src=\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/parlano-di-noi-1.png\" title_text=\"parlano di noi (1)\" url=\"https:\/\/bebeez.it\/venture-capital\/quinto-deal-per-utopia-che-investe-15-mln-euro-sulla-ricerca-antitumorale-di-drug-discovery-clinic\/\" url_new_window=\"on\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][\/et_pb_image][et_pb_image src=\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/8.png\" title_text=\"8\" url=\"https:\/\/startupitalia.eu\/startup\/investimenti\/round-da-15-milioni-di-euro-per-ddc-spin-off-delluniversita-di-torino\/\" url_new_window=\"on\" _builder_version=\"4.24.2\" _module_preset=\"default\" custom_margin=\"30px||||false|false\" global_colors_info=\"{}\"][\/et_pb_image][\/et_pb_column][et_pb_column type=\"1_6\" _builder_version=\"4.24.2\" _module_preset=\"default\" background_color=\"gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14\" custom_padding=\"30px|20px|0px|20px|false|true\" global_colors_info=\"{%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22background_color%22,%22background_color%22%93}\"][et_pb_image src=\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/parlano-di-noi.png\" title_text=\"parlano di noi\" url=\"https:\/\/financecommunity.it\/utopia-sis-investe-in-ddc-un-milione-e-mezzo-di-euro\/\" url_new_window=\"on\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][\/et_pb_image][\/et_pb_column][et_pb_column type=\"1_6\" _builder_version=\"4.24.2\" _module_preset=\"default\" background_color=\"gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14\" custom_padding=\"30px|20px|0px|20px|false|true\" global_colors_info=\"{%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22background_color%22,%22background_color%22%93}\"][et_pb_image src=\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/03\/parlano-di-noi-3.png\" title_text=\"parlano di noi (3)\" url=\"https:\/\/dealflower.it\/health-utopia-sis-investe-15-milioni-in-ddc\/\" url_new_window=\"on\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\"1\" _builder_version=\"4.24.2\" _module_preset=\"default\" background_color=\"gcid-b7a20a05-ac47-46ee-846a-44540a53bb38\" background_enable_mask_style=\"on\" background_mask_style=\"triangles\" background_mask_color=\"gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14\" background_mask_transform=\"invert\" locked=\"off\" global_colors_info=\"{%22gcid-b7a20a05-ac47-46ee-846a-44540a53bb38%22:%91%22background_color%22%93,%22gcid-e5dce679-c214-4f4d-9539-b4f3d3cd1a14%22:%91%22background_mask_color%22%93}\"][et_pb_row column_structure=\"1_4,1_2,1_4\" use_custom_gutter=\"on\" gutter_width=\"2\" make_equal=\"on\" _builder_version=\"4.24.2\" _module_preset=\"default\" width=\"90%\" max_width=\"100%\" global_colors_info=\"{}\"][et_pb_column type=\"1_4\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][\/et_pb_column][et_pb_column type=\"1_2\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_video src=\"https:\/\/www.youtube.com\/watch?v=jvuNa-17G4s\" _builder_version=\"4.24.2\" _module_preset=\"default\" custom_margin=\"||||false|false\" global_colors_info=\"{}\"][\/et_pb_video][\/et_pb_column][et_pb_column type=\"1_4\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][\/et_pb_column][\/et_pb_row][\/et_pb_section]","_et_gb_content_width":"","footnotes":""},"class_list":["post-1042","page","type-page","status-publish","hentry"],"yoast_head":"\nDrug Discovery and Clinic Srl - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE<\/title>\n<meta name=\"description\" content=\"The company\u2019s goal is therefore aimed at developing a technological platform aimed at developing treatments for leukemias and solid tumors.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drug Discovery and Clinic Srl - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE\" \/>\n<meta property=\"og:description\" content=\"The company\u2019s goal is therefore aimed at developing a technological platform aimed at developing treatments for leukemias and solid tumors.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/\" \/>\n<meta property=\"og:site_name\" content=\"UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-08T07:13:52+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/\",\"url\":\"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/\",\"name\":\"Drug Discovery and Clinic Srl - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE\",\"isPartOf\":{\"@id\":\"https:\/\/utopia.p82.it\/#website\"},\"datePublished\":\"2024-02-25T13:53:09+00:00\",\"dateModified\":\"2024-03-08T07:13:52+00:00\",\"description\":\"The company\u2019s goal is therefore aimed at developing a technological platform aimed at developing treatments for leukemias and solid tumors.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.utopiasis.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drug Discovery and Clinic Srl\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/utopia.p82.it\/#website\",\"url\":\"https:\/\/utopia.p82.it\/\",\"name\":\"utopia sis\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/utopia.p82.it\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/utopia.p82.it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/utopia.p82.it\/#organization\",\"name\":\"utopia sis\",\"url\":\"https:\/\/utopia.p82.it\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/utopia.p82.it\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/logo-utopia-v-buona.jpg\",\"contentUrl\":\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/logo-utopia-v-buona.jpg\",\"width\":569,\"height\":191,\"caption\":\"utopia sis\"},\"image\":{\"@id\":\"https:\/\/utopia.p82.it\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drug Discovery and Clinic Srl - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE","description":"The company\u2019s goal is therefore aimed at developing a technological platform aimed at developing treatments for leukemias and solid tumors.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/","og_locale":"en_US","og_type":"article","og_title":"Drug Discovery and Clinic Srl - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE","og_description":"The company\u2019s goal is therefore aimed at developing a technological platform aimed at developing treatments for leukemias and solid tumors.","og_url":"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/","og_site_name":"UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE","article_modified_time":"2024-03-08T07:13:52+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/","url":"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/","name":"Drug Discovery and Clinic Srl - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE","isPartOf":{"@id":"https:\/\/utopia.p82.it\/#website"},"datePublished":"2024-02-25T13:53:09+00:00","dateModified":"2024-03-08T07:13:52+00:00","description":"The company\u2019s goal is therefore aimed at developing a technological platform aimed at developing treatments for leukemias and solid tumors.","breadcrumb":{"@id":"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.utopiasis.it\/en\/drug-discovery-and-clinic-srl\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.utopiasis.it\/en\/"},{"@type":"ListItem","position":2,"name":"Drug Discovery and Clinic Srl"}]},{"@type":"WebSite","@id":"https:\/\/utopia.p82.it\/#website","url":"https:\/\/utopia.p82.it\/","name":"utopia sis","description":"","publisher":{"@id":"https:\/\/utopia.p82.it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/utopia.p82.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/utopia.p82.it\/#organization","name":"utopia sis","url":"https:\/\/utopia.p82.it\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/utopia.p82.it\/#\/schema\/logo\/image\/","url":"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/logo-utopia-v-buona.jpg","contentUrl":"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/logo-utopia-v-buona.jpg","width":569,"height":191,"caption":"utopia sis"},"image":{"@id":"https:\/\/utopia.p82.it\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/pages\/1042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/comments?post=1042"}],"version-history":[{"count":5,"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/pages\/1042\/revisions"}],"predecessor-version":[{"id":1048,"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/pages\/1042\/revisions\/1048"}],"wp:attachment":[{"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/media?parent=1042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}